Related Experiment Video
Updated: Jul 10, 2025
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Omics sciences and precision medicine in testicular cancer
G Madeo1, G Bonetti1,2, P E Maltese1
1MAGI'S LAB, Rovereto (TN), Italy.
Background:
Cancer, a potentially fatal condition, is one of the leading causes of death worldwide. Among males aged 20 to 35, the most common cancer in healthy individuals is testicular cancer, accounting for 1% to 2% of all cancers in men.
Methods:
Throughout this review, we have employed a targeted research approach, carefully handpicking the most representative and relevant articles on the subject. Our methodology involved a systematic review of the scientific literature to ensure a comprehensive and accurate overview of the available sources.
Results:
The onset and spread of testicular cancer are significantly influenced by genetic changes, including mutations in oncogenes, tu-mor suppressor genes, and DNA repair genes. As a result of identifying these specific genetic mutations in cancers, targeted medications have been developed to disrupt the signaling pathways affected by these genetic changes. To improve the diagnosis and treatment of this disease, it is crucial to understand its natural and clinical histories.
Conclusions:
In order to comprehend cancer better and to discover new biomarkers and therapeutic targets, oncologists are increasingly employing omics methods, such as genomics, transcriptomics, proteomics, and metabolomics. Targeted medications that focus on specific genetic pathways and mutations hold promise for advancing the diagnosis and management of this disease.
Insights
Testicular cancer, common in young men, is driven by genetic mutations. Understanding these genetic changes and utilizing omics methods can lead to targeted therapies and improved diagnosis for this disease.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Testicular cancer is a prevalent cancer among males aged 20-35, representing 1-2% of all male cancers.
- Cancer remains a leading global cause of mortality.
Conclusions:
- Omics methods (genomics, transcriptomics, proteomics, metabolomics) are increasingly used to understand cancer and identify new biomarkers and therapeutic targets.
- Targeted medications focusing on specific genetic pathways show promise for improving the diagnosis and management of testicular cancer.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
